IRIS
Bartoletti, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.204
AS - Asia 3.435
EU - Europa 788
SA - Sud America 732
Continente sconosciuto - Info sul continente non disponibili 184
AF - Africa 67
OC - Oceania 9
Totale 10.419
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.019
SG - Singapore 1.780
CN - Cina 774
BR - Brasile 600
VN - Vietnam 412
IT - Italia 237
HK - Hong Kong 124
IE - Irlanda 101
CA - Canada 92
FI - Finlandia 91
GB - Regno Unito 70
DE - Germania 54
BD - Bangladesh 48
RU - Federazione Russa 44
MX - Messico 43
IN - India 42
AR - Argentina 39
FR - Francia 38
MY - Malesia 36
JP - Giappone 32
IQ - Iraq 30
EC - Ecuador 28
NL - Olanda 28
ID - Indonesia 26
PL - Polonia 24
ES - Italia 23
ZA - Sudafrica 23
CO - Colombia 16
TR - Turchia 15
PK - Pakistan 13
JM - Giamaica 12
PE - Perù 12
PY - Paraguay 12
UZ - Uzbekistan 12
SA - Arabia Saudita 11
PH - Filippine 10
SE - Svezia 10
CL - Cile 9
EG - Egitto 9
LT - Lituania 9
UA - Ucraina 9
VE - Venezuela 9
AU - Australia 8
CR - Costa Rica 8
AE - Emirati Arabi Uniti 7
AT - Austria 7
MA - Marocco 7
NP - Nepal 7
IR - Iran 6
KE - Kenya 6
KR - Corea 6
RS - Serbia 6
TN - Tunisia 6
BG - Bulgaria 5
BH - Bahrain 5
DZ - Algeria 5
AL - Albania 4
DO - Repubblica Dominicana 4
EE - Estonia 4
ET - Etiopia 4
IL - Israele 4
JO - Giordania 4
KZ - Kazakistan 4
LB - Libano 4
NI - Nicaragua 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
TW - Taiwan 4
UY - Uruguay 4
AZ - Azerbaigian 3
BE - Belgio 3
GR - Grecia 3
LV - Lettonia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
TH - Thailandia 3
BB - Barbados 2
DK - Danimarca 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
KG - Kirghizistan 2
PT - Portogallo 2
SN - Senegal 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ER - Eritrea 1
GD - Grenada 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
IS - Islanda 1
Totale 10.225
Salva come PNG Salva come JPEG
Città #
Dallas 945
Singapore 704
Ashburn 613
San Jose 596
The Dalles 315
Shanghai 250
Council Bluffs 196
Santa Clara 184
Los Angeles 171
New York 151
Boardman 135
Ho Chi Minh City 132
Beijing 126
Hong Kong 116
Dublin 101
Helsinki 91
Hanoi 82
Milan 69
Phoenix 64
São Paulo 58
Buffalo 51
Chicago 25
Toronto 25
Rio de Janeiro 24
Da Nang 23
Rome 23
Seattle 23
Tokyo 23
Atlanta 22
Brooklyn 22
Orem 22
Brasília 20
Haiphong 20
Mexico City 20
Moscow 20
Warsaw 20
Houston 18
Kuala Lumpur 18
Philadelphia 18
Charlotte 17
Montreal 17
Baghdad 15
Boston 14
Chandler 14
Curitiba 14
Dhaka 14
Princeton 13
Queens 13
Amsterdam 12
Assago 12
Johannesburg 12
San Antonio 12
Chennai 11
Cuenca 11
Miami 11
Riverside 11
Tashkent 11
Belo Horizonte 10
Hangzhou 10
Naples 10
North Bergen 10
London 9
San Francisco 9
Wilmington 9
Bắc Ninh 8
Cairo 8
Frankfurt am Main 8
Jacksonville 8
Jeddah 8
Manchester 8
Denver 7
Lima 7
Paris 7
Pasadena 7
Quito 7
The Bronx 7
Turin 7
Abbeville 6
Asunción 6
Baltimore 6
Genoa 6
Guangzhou 6
Hillsboro 6
Hải Dương 6
Louisville 6
Nairobi 6
Newark 6
Porto Alegre 6
Quảng Ngãi 6
Ribeirão Preto 6
San Bernardino 6
San José 6
Sorocaba 6
Stockholm 6
Vũng Tàu 6
Anaheim 5
Ankara 5
Belfast 5
Biên Hòa 5
Changsha 5
Totale 6.067
Salva come PNG Salva come JPEG
Nome #
What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections? 459
COVID-19 Vaccination Still Makes Sense: Insights on Pneumonia Risk and Hospitalization from a Large-Scale Study at an Academic Tertiary Center in Italy 391
Beyond the distance between juridic and scientific decision-making process: An evidence-based prediction algorithm for professional liability assessment in healthcare-associated infections 138
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis 116
Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study 114
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS‐CoV‐2 infection 105
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 103
Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain 99
The long Pentraxin PTX3 serves as an early predictive biomarker of co-infections in COVID-19 98
Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation 92
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 91
Meningitis caused by toscana virus is associated with strong antiviral response in the CNS and altered frequency of blood antigen-presenting cells 89
Management of Metastatic Endometrial Cancer: Physicians’ Choices Beyond the First Line. A MITO Survey 89
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 88
Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern Italy 87
Bloodstream infections in patients with liver cirrhosis 82
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis 80
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 80
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 79
CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE – a multi-centre experience in Italy 77
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 76
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 76
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 76
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 74
Advances in the therapy of bacterial bloodstream infections 73
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 72
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 71
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 71
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV-infected patients treated with ritonavir-boosted protease inhibitors 70
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 70
Treatment duration for Escherichia coli bloodstream infection and outcomes: Retrospective single-centre study 70
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy 69
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis 68
Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae 68
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 68
Distinct chromosomal mutation associated with cefiderocol resistance in Acinetobacter baumannii: a combined bioinformatics and mass spectrometry approach to unveil and validate the in vivo-acquired chemoresistance 68
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 68
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 68
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 67
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups 67
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 67
Use of critical care resources during the first 2 weeks (February 24–March 8, 2020) of the Covid-19 outbreak in Italy 66
Prevention of infections in nursing homes: Antibiotic prophylaxis versus infection control and antimicrobial stewardship measures 65
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22) 65
Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors 65
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 65
A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study 64
Carbapenemase-producing Enterobacteriaceae in transplant patients 64
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 64
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 64
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 63
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 63
Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors 62
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 62
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience 62
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 62
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 61
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 61
Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape 61
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 60
Toscana virus infections in northern Italy: laboratory and clinical evaluation 60
Opportunistic infections in end stage liver disease 60
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 60
Dialysis-associated infection prevention and surveillance trial: an easy, feasible and effective bundle for infection prevention 60
COVID-19-associated pulmonary aspergillosis, March-August 2020 59
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort 59
ESCMID COVID-19 living guidelines: drug treatment and clinical management 59
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 59
Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines 59
Klebsiella pneumoniae bloodstream infection epidemiology and impact of inappropriate empirical therapy 59
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 58
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 58
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 58
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 58
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 57
Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study 57
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 57
Increase in invasive group A streptococcal infections in Milan, Italy: a genomic and clinical characterization 57
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 56
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation 56
Role of liposomal amphotericin B in intensive care unit: an expert opinion paper 56
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 56
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 56
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis 55
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 55
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 55
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 55
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 54
Microbiology of periprosthetic infections following implant-based breast reconstruction surgery: a multicentric retrospective study 54
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 54
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 54
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 53
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 53
What do clinicians mean by epidemics' preparedness 53
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 53
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 53
Outcome of early treatment of SARS‐CoV‐2 infection in patients with haematological disorders 52
Procalcitonin-guided antibiotic therapy: An expert consensus 52
Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients 52
Management of bacterial and fungal infections in cirrhosis: The MDRO challenge 51
Totale 7.475
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.155
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 1 0 0 0 1 0 0 2 0
2022/2023148 6 0 3 5 1 5 0 5 6 3 111 3
2023/20241.048 65 70 204 37 62 171 89 52 17 51 118 112
2024/20251.580 31 8 19 39 35 203 89 97 285 467 141 166
2025/20265.706 556 617 832 397 227 252 1.213 242 246 385 329 410
2026/20271.922 373 369 886 294 0 0 0 0 0 0 0 0
Totale 10.419